| Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
|---|---|---|---|---|---|---|---|---|
 Filter
|
NARROWPEAK
|
Fei Li
|
||||||
| GSE163623 |
Distinct mechanisms for TMPRSS2 expression explain organ-specific inhibition of SARS-CoV-2 infection by enzalutamide [ChIP-Seq]
|
5 |
|
Fei Li | Dec 22, 2020 | |||
| GSE163624 |
Distinct mechanisms for TMPRSS2 expression explain organ-specific inhibition of SARS-CoV-2 infection by enzalutamide [ATAC-Seq]
|
4 |
|
Fei Li | Dec 22, 2020 | |||
| GSE163632 |
Distinct mechanisms for TMPRSS2 expression explain organ-specific inhibition of SARS-CoV-2 infection by enzalutamide
|
9 |
|
Fei Li | Dec 22, 2020 | |||
| GSE191181 |
Evaluation of chromatin accessibility during prostate cancer progression
|
2 |
|
Fei Li | Oct 31, 2022 | |||
| GSE191182 |
Regulatory cistrome landscape of Foxa1 and Foxa2 during prostate cancer progression [ChIP-seq]
|
6 |
|
Fei Li | Oct 31, 2022 |
